Eirhub

#FridayMeme>> Have you been waiting for our Friday meme? 😎 Because it's on its way! 🎉 ✍🏼 Leave a comment if you have more than 4 open tabs #Eirhub #pharmaceuticals #EasternEurope

💰 Recent biotech funding and start-up activities by BiopharmIQ by Amp 𝐏𝐨𝐬𝐭-𝐈𝐏𝐎/𝐏𝐮𝐛𝐥𝐢𝐜 𝐅𝐮𝐧𝐝𝐢𝐧𝐠 Cartesian Therapeutics - Raised $130M in post-IPO funding to advance its programs and general corporate goals. Bionano - Announced a $30M public offering, including $10M upfront and $20M through warrants linked to the achievement of clinical milestones. e-therapeutics PLC - Completed £28.9M of post-IPO funding to advance several of its developments, including GalOmic™. InspireMD - Utilised $17.9M of Series H warrants following the successful results of the C-GUARDIAN study. Checkpoint Therapeutics Inc - Raised $12M in a private placement to support working capital and corporate purposes. 𝗣𝗿𝗶𝘃𝗮𝘁𝗲 𝗙𝘂𝗻𝗱𝗶𝗻𝗴 Myricx Bio - Raised £90M in Series A round to develop its innovative ADC platform. Circle Pharma, Inc. - Raised $54.1M in private equity, strengthening its financial position. Kanvas Biosciences - Raised an additional $12.5M to advance its microbiome-based immuno-oncology business. AnBogen Therapeutics - Completed a $7.3M Series A+ financing round to further advance its Phase 2 clinical trial of ABT-301. Granza Bio (YC W24) - Raised $7.14M in a seed round, backed by Felicis and Refactor, to advance its oncology and autoimmune disease pipeline. Source: https://lnkd.in/g46ZDXuq #biotech #biopharma

#healthcare >> About 20,000 patients with multiple sclerosis are officially registered in Ukraine, but due to the lack of a national registry, the actual number may be many times higher. The main problem is the difficulty of accessing innovative treatments that can prevent the development of the disease and avoid disability. Roche develops innovative medicines, including a drug for primary progressive MS. Primary progressive MS may affect young people on the verge of their most productive years, manifesting in severe and unrelenting symptoms and resulting in rapid disability. Unfortunately, in Ukraine, patients have limited access to the drug due to a lack of state funding. The main difficulties in providing treatment are related to the w@@r, infrastructure destruction, and economic situation. In 2024, government spending on healthcare in Ukraine will be less than 3% of GDP although the need is at least 5%. Roche launched the "United for Health" program which provides additional packages of medication to medical institutions. They are in constant dialogue with the Ministry of Health to ensure patients have access to innovative drugs funded by the state as well as offer a patient support discount program and conduct educational campaigns to raise awareness about MS. Inadequate access to treatment reduces patient productivity, impacting the country’s economy. For example, in the EU, 80% of MS patients can continue to work, whereas in Ukraine only 1 in 3 can. Eirhub collaborated with Roche Ukraine to estimate annual economic losses from reduced productivity and caregiving costs to be around 50 million euros. This figure underscores the urgent need for improved healthcare funding and access to innovative treatments to mitigate long-term economic impacts. Full article: https://lnkd.in/duyfx2wK #healthcare #Ukraine #EasternEurope

Will the Ukrainian clinical trials (CTs) industry recover soon? Today, the Ukrainian CT industry is resilient despite all the challenges. 𝗪𝗵𝘆 𝗶𝘀 𝘁𝗵𝗶𝘀 𝗶𝗺𝗽𝗼𝗿𝘁𝗮𝗻𝘁? Before the invasion, Ukraine was becoming a key center for CTs: in 2021, there were almost 800 active trials in the country. In early 2023, more than 40 multinational trials were interrupted. As of 2Q 2024, the total number of ongoing CTs in Ukraine reached 358, including 25 started in 1Q 2024, and another 81 CTs were approved by the Ministry of Health to start. 𝗧𝗵𝗲 𝗯𝗶𝗴 𝗽𝗶𝗰𝘁𝘂𝗿𝗲: The latest report from the State Expert Center (SEC) highlights that 11 new CTs were approved in Q2 2024, with no temporary suspensions or terminations of new patient enrolment recorded. The year 2024 saw no temporary cessation of any other CTs in Ukraine. This stability demonstrates the reliability of CT in Ukraine in the context of w@@@r, which could potentially attract more International investments and collaborations. 𝗕𝗲𝘁𝘄𝗲𝗲𝗻 𝘁𝗵𝗲 𝗹𝗶𝗻𝗲𝘀: The adaptability of Ukraine's clinical trial industry suggests a broader resilience in the country's healthcare system. This resilience can lead to increased international collaboration and funding, bolstering Ukraine's position as a key player in clinical trials. 𝗧𝗵𝗲 𝗯𝗮𝗰𝗸𝘀𝘁𝗼𝗿𝘆: Historically, the CTs sector in Ukraine has been strong due to its highly educated population and advanced digital medical solutions. Despite the devastation caused by the w@@@r, the sector has adapted, found innovative solutions to logistical challenges, and accelerated trial approval. Part of this adaptability has been driven by lessons learned during COVID-19 when remote monitoring and creative solutions for transporting biospecimens became the norm. 𝗪𝗵𝗮𝘁 𝗶𝘀 𝗻𝗲𝘅𝘁? Ukraine's clinical trials industry is ready to recover, provided that it has strong support from the government and international companies. Ukraine's clinical trials industry is ready to recover with strong support from the government and international companies, so with further support, Ukraine could become a key CT hub. Full report: https://lnkd.in/eVv5aMj9 Keywords: #clinicaltrials #Ukraine #easterneurope #healthcare

#Healthcare >> 🚭 The World Health Organization (WHO) has released its first-ever clinical treatment guideline for tobacco cessation, a crucial step in our global fight against tobacco-related diseases. Key Highlights: 🔹 Comprehensive interventions: Behavioural support, digital tools, and pharmacological treatments. 🔹 Focus on the 750 million+ tobacco users eager to quit. 🔹 Effective therapies: Varenicline, NRT, bupropion, and cytisine. 🔹 New prequalification procedure to enhance global access to cessation medications. 🔹 Emphasis on accessibility, especially in low- and middle-income countries. Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, emphasizes that these guidelines are essential tools for supporting individuals in their journey to quit tobacco. Dr. Rüdiger Krech, Director of Health Promotion at WHO, highlights the immense struggle of quitting and the need for robust support systems. 🌍 WHO calls on healthcare providers, policy-makers, and stakeholders to implement these guidelines and improve health outcomes for millions globally. Full article: https://lnkd.in/d6ZrHwuC #Healthcare #EasternEurope

𝗝𝘂𝗹𝘆 𝟵 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗱𝗲𝗰𝗹𝗮𝗿𝗲𝗱 𝗮 𝗗𝗮𝘆 𝗼𝗳 𝗠𝗼𝘂𝗿𝗻𝗶𝗻𝗴 𝗱𝘂𝗲 𝘁𝗼 𝘁𝗵𝗲 𝗱𝗲𝘃𝗮𝘀𝘁𝗮𝘁𝗶𝗻𝗴 𝗿𝗼𝗰𝗸𝗲𝘁 𝘀𝘁𝗿𝗶𝗸𝗲𝘀 𝘁𝗵𝗮𝘁 𝗵𝗶𝘁 𝗰𝗶𝘁𝗶𝗲𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝗨𝗸𝗿𝗮𝗶𝗻𝗲 𝗼𝗻 𝗝𝘂𝗹𝘆 𝟴, 𝟮𝟬𝟮𝟰 𝗯𝘆 𝗥𝘂𝘀𝘀𝗶𝗮. As of now, it is known that 38 people have tragically lost their lives, including four children. 190 people have been injured. Currently, 64 individuals are hospitalized in Kyiv, 28 in Kryvyi Rih, and 6 in Dnipro. Our thoughts and prayers are with all those affected by this act of terror. In Kyiv, three hospitals were affected: 𝗢𝗵𝗺𝗮𝘁𝗱𝘆𝘁 𝗖𝗵𝗶𝗹𝗱𝗿𝗲𝗻'𝘀 𝗛𝗼𝘀𝗽𝗶𝘁𝗮𝗹, as well as the 𝗜𝘀𝗶𝗱𝗮 and 𝗔𝗗𝗢𝗡𝗜𝗦 Hospitals. Doctors are completing surgeries in partially destroyed operating rooms, and children are being evacuated to other hospitals across our country. At the same time, we are grateful for all the people who have united and supported the hospitals with their collective efforts. Businesses are donating large sums for reconstruction, and ordinary people are bringing necessary supplies and assisting in clearing the debris. Eternal memory to the victims of the terror attack! 🙏🏼 Eirhub Team 

#FridayMeme>> 😄 Time for a Friday meme! Admit it, you've been there, haven't you? 👀 #LifeSciencesrecruitment #Eirhub #pharmaceuticals #EasternEurope

#Ukraine >> ❤️🩹 Addressing Healthcare Challenges in W@r-Affected Ukraine: Humanitarian Interventions and Long-Term Resilience 𝗧𝗟𝗧𝗥: Humanitarian health programming in w@r-affected Ukraine focuses on filling critical gaps in healthcare services. 𝗪𝗵𝘆 𝗶𝘁 𝗺𝗮𝘁𝘁𝗲𝗿𝘀: Ukraine's ongoing w@r has severely disrupted healthcare access, particularly in frontline regions. The humanitarian response aims to bridge these gaps and ensure vulnerable populations receive essential medical care. 𝗧𝗵𝗲 𝗯𝗶𝗴 𝗽𝗶𝗰𝘁𝘂𝗿𝗲: Effective programming hinges on collaboration with local health authorities and comprehensive contextual assessments. By leveraging existing frameworks and partnerships, interventions like voucher systems and mobile medical units address immediate health needs while supporting long-term health system resilience. 𝗕𝗲𝘁𝘄𝗲𝗲𝗻 𝘁𝗵𝗲 𝗹𝗶𝗻𝗲𝘀: Beyond immediate health interventions, this approach aims to strengthen health infrastructure and ensure sustainability. It involves navigating logistical challenges and aligning with national healthcare frameworks to maximize impact. 𝗧𝗵𝗲 𝗯𝗮𝗰𝗸𝘀𝘁𝗼𝗿𝘆: The w@r in Ukraine has exacerbated existing healthcare challenges, including limited access to medicines and healthcare facilities. Humanitarian actors face the dual challenge of responding to immediate health crises while planning for long-term recovery and stability. 𝗪𝗵𝗮𝘁'𝘀 𝗻𝗲𝘅𝘁: Continued efforts will focus on monitoring and evaluation to adapt interventions, enhance accountability, and support sustainable health outcomes in w@r-affected regions of Ukraine. The success of these initiatives will depend on ongoing collaboration, innovation, and adaptation to evolving humanitarian needs. 𝗙𝘂𝗹𝗹 𝗿𝗲𝗽𝗼𝗿𝘁: https://lnkd.in/dXT9qZqa #Ukraine #HumanitarianAid #Healthcare #RecoveryAndStability

#recruitment in #pharma 💡 Attention Job Seekers in the Pharma Industry: Interview Preparation Tips. 👉 If you're aiming to land a job, switch career paths, or explore new opportunities in the life sciences sector, this article is a must-read. It provides practical and valuable insights on everything from initial preparations and researching potential interviewers to handling crucial interview questions, ensuring you're fully prepared for your next interview. Our co-founder and Recruitment Partner, Anastasiia Maksymenko, a seasoned professional in the pharmaceutical industry, shares invaluable advice on the key aspects of interviewing with potential employers and candidates. Her expertise will instill confidence in the advice you receive.👇👇👇 #recruitment #Ukraine #EasternEurope #Europe #pharmaceuticals #lifesciences #eirhub #executivesearch

#DigitalHealth >> 🌟 Exciting Update for Healthcare in Ukraine! 📱 The Ukrainian government has recently passed a resolution that will display medical data in the Diia app. This means that Ukrainians will now have the convenience of registering themselves as patients in the electronic healthcare system, choosing a family doctor, and submitting or terminating declarations, all through Diia. No more need to visit the hospital and spend time on these tasks! In addition, updating personal information like a new phone number or address in the electronic healthcare system will soon be just a few clicks away in Diia. Currently, such updates require a visit to the clinic or contacting the National Health Service. This digital transformation will streamline the process, making it simpler and faster. 🇺🇦 This initiative is a significant step towards modernizing healthcare in Ukraine, ensuring that essential services are accessible to everyone, and enhancing the efficiency of the healthcare system. Full article: https://lnkd.in/djfM8PmA #Ukraine #DigitalHealth #Diia #healthcare #innovation #healthsystems #EasternEurope